Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans

被引:22
|
作者
Patterson, TF [1 ]
Kirkpatrick, WR [1 ]
Revankar, SG [1 ]
McAtee, RK [1 ]
Fothergill, AW [1 ]
McCarthy, DI [1 ]
Rinaldi, MG [1 ]
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284
关键词
D O I
10.1128/JCM.34.12.3237-3239.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A simple screening method for fluconazole susceptibility using CHROMagar Candida with fluconazole,vas compared with the National Committee for Clinical Laboratory Standards (NCCLS) macrobroth method. In this agar dilution method, susceptible Candida albicans colonies are smaller on medium,vith fluconazole than on fluconazole-free medium. Yeasts with decreased susceptibility have normal-sized colonies on medium containing fluconazole. On agar with 16 mu g of fluconazole per mi, 32 of 34 strains with NCCLS MICs of greater than or equal to 16 mu g/ml were correctly predicted, as were 66 of 68 with MICs of <16, an agreement of 96%. On agar with 8 mu g of fluconazole per mi, 38 of 41 isolates with MICs of greater than or equal to 8 were correctly predicted, as were 59 of 61 isolates with MICs of <8, an agreement of 95%. This agar dilution method appears to highly correlate with NCCLS macrobroth methods for detection of C. albicans and may be an effective screen for fluconazole susceptibility.
引用
收藏
页码:3237 / 3239
页数:3
相关论文
共 50 条
  • [31] Quantitation of ergosterol content:: Novel method for determination of fluconazole susceptibility of Candida albicans
    Arthington-Skaggs, BA
    Jradi, H
    Desai, T
    Morrison, CJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) : 3332 - 3337
  • [32] Usefulness of conda Candida chromogenic agar for primary isolation and presumptive identification of Candida albicans and other clinically relevant yeasts
    Eraso, E.
    Marcos-Arias, C.
    Ortega-Riveros, M.
    Varona, A.
    Gil-Alonso, S.
    Miranda-Zapico, I.
    Ginestal, E.
    Aguirre, J. M.
    Quindos, G.
    MYCOSES, 2011, 54 : 77 - 78
  • [33] Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations
    Xu, Yonghao
    Chen, Lamei
    Li, Chunyang
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 798 - 804
  • [34] IN-VITRO SUSCEPTIBILITY OF CANDIDA SPECIES TO FLUCONAZOLE BY MICRODILUTION TEST AND AGAR DIFFUSION TEST
    METZGER, S
    JAGER, H
    HOFMANN, H
    MYCOSES, 1994, 37 : 64 - 70
  • [35] Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole
    Lee, Sai-Cheong
    Lo, Hsiu-Jung
    Fung, Chang-Phone
    Lee, Ning
    See, Lai-Chu
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2009, 42 (02) : 148 - 153
  • [36] Comparative Antifungal Susceptibility Analysis of Candida albicans Versus Non-albicans Candida Corneal Isolates
    Spierer, Oriel
    Dugar, Jyoti
    Miller, Darlene
    O'Brien, Terrence P.
    CORNEA, 2015, 34 (05) : 576 - 579
  • [37] Chronic recurrent vulvovaginal candidosis caused by Candida albicans with reduced fluconazole susceptibility in vitro
    Dolgo-Saburova, J. V.
    Zhorzh, O. N.
    Vibornova, I. V.
    Shurpitskaya, O. A.
    Raush, E. R.
    Bogomolova, T. S.
    Klimko, N. N.
    MYCOSES, 2017, 60 : 231 - 231
  • [38] Fluconazole Susceptibility and Genotypic Analysis of Candida albicans from Clinical Sources in Nairobi, Kenya
    Chemutai, B. C.
    Korir, R. K.
    Mashedi, O. M.
    Gatumwa, E.
    Kangogo, M. C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E277 - E278
  • [39] Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile
    Sadeghi, G.
    Ebrahimi-Rad, M.
    Mousavi, S. F.
    Shams-Ghahfarokhi, M.
    Razzaghi-Abyaneh, M.
    JOURNAL DE MYCOLOGIE MEDICALE, 2018, 28 (01): : 51 - 58
  • [40] Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice
    Khan, MA
    Khan, A
    Owais, M
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2006, 46 (01): : 63 - 69